CN Stock MarketDetailed Quotes
301009 Hangzhou Coco Healthcare Products
- 14.35
- +2.26+18.69%
Market Closed Dec 20 15:00 CST
3.90BMarket Cap260.91P/E (TTM)
14.51High11.98Low439.06KlotVolume11.98Open12.09Pre Close611.78MTurnover33.63%Turnover Ratio193.92P/E (Static)271.86MShares14.8352wk High2.90P/B1.87BFloat Cap6.7352wk Low14.51Limit Up130.56MShs Float38.08Historical High9.67Limit Down20.93%Amplitude6.73Historical Low0.08Dividend TTM13.93Avg Price195.05KlotAsk0.52%Div YieldTTM100Lot Size212.15KlotBid
Hangzhou Coco Healthcare Products Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.19%789.11M | -7.42%520.87M | -11.24%282.97M | -8.83%1.08B | -4.99%806.77M | -2.35%562.6M | -0.88%318.79M | -0.01%1.19B | -2.02%849.12M | -8.59%576.13M |
| Operating revenue | -2.19%789.11M | -7.42%520.87M | -11.24%282.97M | -8.83%1.08B | -4.99%806.77M | -2.35%562.6M | -0.88%318.79M | -0.01%1.19B | -2.02%849.12M | -8.59%576.13M |
| Other operating revenue | ---- | -50.86%8.11M | ---- | 36.08%27.55M | ---- | 78.32%16.51M | ---- | 25.07%20.24M | ---- | 5.19%9.26M |
| Total operating cost | -0.26%766.57M | -6.98%492.68M | -14.65%260.39M | -10.45%1.05B | -8.35%768.59M | -8.23%529.68M | -4.17%305.07M | 2.75%1.17B | 5.99%838.6M | 4.03%577.16M |
| Operating cost | -5.87%619.29M | -12.38%406.62M | -15.28%225.27M | -13.61%890.56M | -11.53%657.89M | -8.28%464.07M | -5.99%265.89M | 6.79%1.03B | 11.05%743.67M | 5.69%505.94M |
| Operating tax surcharges | -21.34%5.23M | -34.04%3.18M | -45.29%1.47M | 144.60%7.66M | 109.01%6.65M | 120.72%4.82M | 268.65%2.69M | -26.49%3.13M | -2.20%3.18M | -15.52%2.18M |
| Operating expense | 37.57%94.6M | 36.89%59.23M | 10.53%23.11M | 4.51%99.47M | -2.49%68.77M | -13.08%43.27M | -5.74%20.9M | 4.96%95.18M | 11.85%70.53M | 33.53%49.78M |
| Administration expense | -2.78%26.29M | 9.71%16.81M | 39.45%8.9M | 18.59%35.97M | 20.16%27.04M | -0.83%15.32M | -2.75%6.38M | -18.39%30.33M | -11.07%22.5M | 36.20%15.45M |
| Financial expense | 53.20%-11.69M | 24.80%-14.88M | -601.23%-8.57M | 26.49%-28.48M | 36.29%-24.99M | 7.07%-19.78M | 76.87%-1.22M | -515.36%-38.75M | -546.16%-39.22M | -1,823.19%-21.29M |
| -Interest expense (Financial expense) | 2.83%483.79K | 31.38%330.52K | 213.15%173.24K | 135.50%650.61K | 112.34%470.49K | 58.76%251.58K | -37.19%55.32K | -71.27%276.27K | -74.30%221.57K | -81.22%158.47K |
| -Interest Income (Financial expense) | 7.37%-16.3M | -9.15%-12.22M | -27.35%-6.93M | -3.87%-24.25M | 0.77%-17.59M | 6.74%-11.2M | 9.58%-5.44M | -84.57%-23.35M | -77.23%-17.73M | -297.32%-12.01M |
| Research and development | -1.14%32.86M | -1.21%21.72M | -2.07%10.22M | -13.49%44.11M | -12.40%33.24M | -12.40%21.99M | -8.20%10.43M | 3.47%50.98M | 5.49%37.94M | 6.20%25.1M |
| Credit Impairment Loss | -184.34%-1.57M | -366.06%-2.37M | 3.50%-1.62M | 145.90%2.56M | 151.20%1.87M | 120.82%891.43K | 49.17%-1.68M | -119.09%-5.57M | -202.65%-3.65M | -910.50%-4.28M |
| Asset Impairment Loss | 65.14%-4.64M | 74.23%-3.02M | 14.22%-1.31M | 68.38%-23.12M | -284.39%-13.3M | -381.71%-11.7M | -669.07%-1.53M | -831.44%-73.11M | -138.64%-3.46M | -292.32%-2.43M |
| Other net revenue | 102.13%202.43K | 81.55%-1.75M | -17.37%-1.78M | 82.90%-11.96M | -5,632.73%-9.51M | -282.05%-9.46M | 46.79%-1.52M | -9,907.93%-69.98M | -97.17%171.8K | -173.09%-2.48M |
| Fair value change income | ---- | ---- | ---- | ---- | ---2.11M | ---2.15M | ---- | ---- | ---- | ---- |
| Invest income | 53.12%-973.04K | -1,002.09%-1.57M | ---885.97K | -1,521.38%-3.34M | -982.91%-2.08M | -160.61%-142.48K | ---- | -95.35%235.09K | -85.88%235.09K | -86.59%235.09K |
| -Including: Investment income associates | -766.86%-2.19M | -1,002.09%-1.57M | ---885.97K | ---1.11M | ---252.66K | ---142.48K | ---- | ---- | ---- | ---- |
| Asset deal income | 46,945.92%63.99K | 31,851.00%43.37K | ---- | -185.99%-103.61K | -100.09%-136.59 | 97.83%-136.59 | -144.42%-136.59 | 168.59%120.49K | 82.28%160.04K | -107.85%-6.3K |
| Other revenue | 19.73%7.32M | 41.84%5.17M | 20.36%2.04M | 44.21%12.04M | -11.15%6.12M | -9.02%3.64M | 303.37%1.7M | 81.64%8.35M | 209.34%6.88M | 143.23%4.01M |
| Operating profit | -20.69%22.74M | 12.74%26.45M | 70.45%20.8M | 136.48%20.23M | 168.09%28.67M | 768.88%23.46M | 2,808.24%12.2M | -222.44%-55.47M | -86.87%10.7M | -104.45%-3.51M |
| Add:Non operating Income | 1,069.40%2.43M | 172.97%389.29K | 613.33%105.6K | -40.26%418.74K | 29.74%207.84K | 483.01%142.61K | -40.21%14.8K | 490.70%700.9K | 679.77%160.21K | -68.69%24.46K |
| Less:Non operating expense | -75.55%232.76K | -97.32%19.26K | -87.99%19.23K | -25.36%1.2M | 499.67%952.07K | 376.78%717.72K | 30,701.19%160.16K | -15.04%1.61M | -86.88%158.77K | 1,238.51%150.54K |
| Total profit | -10.71%24.94M | 17.19%26.82M | 73.22%20.89M | 134.51%19.45M | 161.09%27.93M | 729.83%22.88M | 2,616.67%12.06M | -229.50%-56.37M | -86.68%10.7M | -104.60%-3.63M |
| Less:Income tax cost | 41.60%2.96M | 115.22%3.43M | 206.51%2.68M | 1,446.92%1.69M | 194.39%2.09M | 157.35%1.59M | 208.68%875.62K | -103.07%-125.54K | -129.11%-2.22M | -133.26%-2.78M |
| Net profit | -14.94%21.98M | 9.86%23.39M | 62.79%18.2M | 131.58%17.76M | 100.08%25.84M | 2,582.86%21.29M | 794.97%11.18M | -242.62%-56.25M | -82.23%12.91M | -101.21%-857.49K |
| Net profit from continuing operation | -14.94%21.98M | 9.86%23.39M | 62.79%18.2M | 131.58%17.76M | 100.08%25.84M | 2,582.86%21.29M | 794.97%11.18M | -242.62%-56.25M | -82.23%12.91M | -101.21%-857.49K |
| Less:Minority Profit | 93.10%-94.26K | 129.31%174.64K | -249.03%-127.66K | 81.53%-2.42M | 26.46%-1.37M | 57.81%-595.91K | 112.10%85.66K | -4,165.68%-13.12M | -157.45%-1.86M | -143.41%-1.41M |
| Net profit of parent company owners | -18.87%22.07M | 6.07%23.22M | 65.19%18.33M | 146.80%20.18M | 84.17%27.2M | 3,844.05%21.89M | 466.92%11.1M | -208.51%-43.13M | -78.73%14.77M | -99.18%554.91K |
| Earning per share | ||||||||||
| Basic earning per share | -18.18%0.0819 | 6.71%0.0859 | 65.20%0.0674 | 143.75%0.07 | 84.35%0.1001 | 3,925.00%0.0805 | 466.67%0.0408 | -194.12%-0.16 | -78.75%0.0543 | -99.39%0.002 |
| Diluted earning per share | -18.18%0.0819 | 6.71%0.0859 | 65.20%0.0674 | 143.75%0.07 | 84.35%0.1001 | 3,925.00%0.0805 | 466.67%0.0408 | -194.12%-0.16 | -78.75%0.0543 | -99.39%0.002 |
| Other composite income | 133.65%1.96K | 83.76%-1.15K | -112.73%-319.77 | 78.70%-3.21K | 68.80%-5.82K | 17.45%-7.06K | 258.43%2.51K | -519.53%-15.05K | -2,079.08%-18.64K | -652.95%-8.55K |
| Other composite income of parent company owners | 133.65%1.96K | 83.76%-1.15K | -112.73%-319.77 | 78.70%-3.21K | 68.80%-5.82K | 17.45%-7.06K | 258.43%2.51K | -519.53%-15.05K | -2,079.08%-18.64K | -652.95%-8.55K |
| Total composite income | -14.92%21.98M | 9.89%23.39M | 62.75%18.2M | 131.56%17.76M | 100.33%25.83M | 2,557.52%21.28M | 794.67%11.19M | -242.65%-56.26M | -82.26%12.89M | -101.23%-866.04K |
| Total composite income of parent company owners | -18.84%22.07M | 6.10%23.21M | 65.15%18.33M | 146.78%20.18M | 84.36%27.2M | 3,904.49%21.88M | 466.84%11.1M | -208.54%-43.14M | -78.76%14.75M | -99.19%546.36K |
| Total composite income of minority owners | 93.10%-94.26K | 129.31%174.64K | -249.03%-127.66K | 81.53%-2.42M | 26.46%-1.37M | 57.81%-595.91K | 112.10%85.66K | -4,165.68%-13.12M | -157.45%-1.86M | -143.41%-1.41M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
